ARCHIVES

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

This article is from The Cancer Letter archive.

Vol. 35 No. 17 | May 1, 2009

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Advocacy Groups Consider Pros And Cons Of Forming Co-Pay Foundations.

April 28, 2006

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

Patch-Lozenge Combination Best For Smoking Cessation

November 27, 2009

FCRF Recompetition Notice Of Intent

September 19, 1980